Dr. Anil K D’Cruz is a highly respected senior oncologist consulting in Delhi with a focused clinical interest in the management of thyroid cancer. With over three decades of experience in oncologic care, he brings deep expertise in the evaluation, surgical treatment, and long-term management of thyroid malignancies, offering patients in Delhi access to nationally recognised clinical leadership.
He holds multiple prestigious qualifications, including MS, DNB, and FRCS, reflecting his commitment to advanced medical training and excellence in cancer care. At Apollo Athenaa Women’s Cancer Centre, Delhi, Dr. D’Cruz works closely with a multidisciplinary oncology team to ensure accurate diagnosis, evidence-based treatment planning, and comprehensive follow-up for patients with thyroid cancer.
Dr. D’Cruz is known for his patient-centric approach, combining precision surgical techniques, modern diagnostic support, and personalised care pathways. His clinical philosophy emphasises clear communication, informed decision-making, and compassionate support throughout the treatment journey. Fluent in English, Hindi, and Marathi, he is able to connect effectively with patients from diverse backgrounds.
As part of the Apollo oncology ecosystem in Delhi, Dr. D’Cruz contributes to a structured and collaborative model of care that integrates surgical oncology, endocrinology, pathology, radiology, and rehabilitation. His role at Apollo Athenaa strengthens the centre’s ability to deliver specialised thyroid cancer care with a strong focus on safety, outcomes, and long-term patient wellbeing.
He is currently President Elect (2018–2020) and President (2020–2022) of the Union International for Cancer Control, headquartered in Geneva. He is the first Indian to hold this position. Patients consulting Dr. Anil K D’Cruz in Delhi benefit from his extensive experience, methodical approach to thyroid cancer treatment, and commitment to delivering high-quality, ethical, and compassionate cancer care.
Head & neck cancers
Oral cavity cancers
Laryngeal cancers
Thyroid cancer
Parathyroid cancer
Laser surgery
Early detection of cancers
MBBS
MS
DNB – General Surgery
FRCS (Hon.)
Derived from verified patient bills.
Dr. Anil K D’Cruz is a highly respected senior oncologist consulting in Delhi with a focused clinical interest in the management of thyroid cancer. With over three decades of experience in oncologic care, he brings deep expertise in the evaluation, surgical treatment, and long-term management of thyroid malignancies, offering patients in Delhi access to nationally recognised clinical leadership.
He holds multiple prestigious qualifications, including MS, DNB, and FRCS, reflecting his commitment to advanced medical training and excellence in cancer care. At Apollo Athenaa Women’s Cancer Centre, Delhi, Dr. D’Cruz works closely with a multidisciplinary oncology team to ensure accurate diagnosis, evidence-based treatment planning, and comprehensive follow-up for patients with thyroid cancer.
Dr. D’Cruz is known for his patient-centric approach, combining precision surgical techniques, modern diagnostic support, and personalised care pathways. His clinical philosophy emphasises clear communication, informed decision-making, and compassionate support throughout the treatment journey. Fluent in English, Hindi, and Marathi, he is able to connect effectively with patients from diverse backgrounds.
As part of the Apollo oncology ecosystem in Delhi, Dr. D’Cruz contributes to a structured and collaborative model of care that integrates surgical oncology, endocrinology, pathology, radiology, and rehabilitation. His role at Apollo Athenaa strengthens the centre’s ability to deliver specialised thyroid cancer care with a strong focus on safety, outcomes, and long-term patient wellbeing.
He is currently President Elect (2018–2020) and President (2020–2022) of the Union International for Cancer Control, headquartered in Geneva. He is the first Indian to hold this position. Patients consulting Dr. Anil K D’Cruz in Delhi benefit from his extensive experience, methodical approach to thyroid cancer treatment, and commitment to delivering high-quality, ethical, and compassionate cancer care.
